Thanks Pharma. The full H&G ASX announcement provides insight...

Thanks Pharma. The full H&G ASX announcement provides insight into its opportunistic in & out M&A modus operandi which I find disconcerting as a long term CDY/AN1 shareholder.

I don’t foresee H&G’s stake in AN1 being long term; rather to creatively flip it in one deal or another once the metrics meet its investment benchmarks. That game plan would surely put a cap on the sp upside (and time frame) we have been hoping and wishing for over past years.

Long term holders, even if having averaged down, would know that the sp would have to double from here and double again and again multiple times to even break even on our respective entry costs.

Consider the writing is on the wall that opportunity won’t arise, given that H&G is probably not a White Knight after all.